Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Soluble Syndecan 1 as Biomarker for Acute and Chronic Bowel Inflammation

NCT02333526 is registered in ClinicalTrials.gov with Helios Albert-Schweitzer-Klinik Northeim as lead sponsor.

NCT NCT02333526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02333526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Soluble Syndecan 1 as Biomarker for Acute and Chronic Bowel Inflammation
Lead sponsor
Helios Albert-Schweitzer-Klinik Northeim
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2019
Completion date
July 31, 2020
Enrollment
44 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colitis